Author: TroyFlowers

Study Indicates Cannabis Use Might Have Less Impact on Young Brains than You Think

Another scientific research study has been conducted on the effects that cannabis might have on developing young brains, and the results further suggests that the age-old stigma that ‘pot makes kids stupid’ could be complete and utter nonsense. The author of this particular study analyzed data that was compiled from various others of its kind, which were done on teenage and young adults who used the plant heavily. According to CNN, the main focus of the study was how cannabis might have impacted the participants’ executive functioning skills. The study was done by Assistant Professor of Psychiatry Cobb Scott,...

Read More

04-19-2018 – Cannabis News with Joe Klare

Joe Klare discusses a CBD medication under review by the FDA, more possible problems with adult use legalization in New Jersey and a new survey from Eaze about 4/20. 04-19-2018 – Ep. 119 | Marijuana Times Show https://www.marijuanatimes.org/cbd-medication-epidiolex-receives-a-positive-review-from-the-fda/ https://whyy.org/segments/murphy-move-to-legalize-recreational-pot-gets-fractured-response-from-n-j-delegation/ https://www.eaze.com/article/eaze-insights-people-opening-up-cannabis-use-own-it-survey-legalization-quarterly-report-marijuana http://naturecidecannabis.com/ TroyFlowers Author description...

Read More

S.C. Medical Marijuana Legislation Continues Making Progress with Approval from House 3M Committee Today

Committee passed bill 14-3, which will go to the full House for consideration; Senate version approved by Medical Affairs Committee in March COLUMBIA, S.C. — The House Medical, Military, Public and Municipal Affairs (3M) Committee overwhelmingly approved a medical marijuana bill on Thursday in a vote of 14-3, sending it to the full House for consideration. The South Carolina Compassionate Care Act, known as H 3521 in the House, would allow seriously ill patients to use marijuana to treat their conditions with a recommendation from their doctors. The legislature’s crossover deadline has already passed, but this vote, combined with approval by...

Read More

CBD Medication Epidiolex Receives a Positive Review from the FDA

It’s been some time since we started seeing news about a CBD (cannabidiol) based medicine  called Epidiolex being developed by the British company GW Pharmaceuticals. The marijuana-derived cannabinoid has proven useful in the treatment of seizures – and GW Pharmaceuticals has been conducting a drug trial using Epidiolex to treat two rare forms of intractable epilepsy, Dravet syndrome and Lennox-Gastaut syndrome (LGS), and the results of those trials are currently under review by the U.S. Food and Drug Administration (FDA) . If Epidiolex is approved by the FDA, then it will be one of the first cannabinoid-based medications –...

Read More

04-18-2018 – Cannabis News with Joe Klare

Joe Klare discusses the prospects for recreational legalization in Australia, how Lyft is celebrating 4/20 and a new study on cannabis’ effects on adolescent brains. 04-18-2018 – Ep. 118 | Marijuana Times Show https://www.marijuanatimes.org/is-recreational-marijuana-legalization-dead-in-australia/ https://www.forbes.com/sites/tomangell/2018/04/17/lyft-celebrates-420-with-discounts-in-legal-marijuana-states/#2da074fc16b3 https://www.cnn.com/2018/04/18/health/marijuana-cognitive-effects-study/index.html Sponsor: http://naturecidecannabis.com/ TroyFlowers Author description...

Read More

Global Cannabis Pioneer Tikun Olam and Ilera Healthcare Announce Pennsylvania Partnership to Deliver Science-Backed Cannabis Products to PA MMJ Patients

PHILADELPHIA, PA and NEW YORK, NY (APRIL 17, 2018) – Tikun Olam, the world leader in cannabis science, and Ilera Healthcare, Pennsylvania’s premier medical marijuana cultivator, processor and dispenser, have finalized a deal to bring Tikun’s world-renowned medical marijuana strains to medical cannabis patients in the Keystone State later this year. This partnership combines Tikun Olam’s history of peer-reviewed scientific research and unprecedented clinical data collection with Ilera’s expertise in formulating and delivering high-quality pharmaceutical-grade medical cannabis products to Pennsylvanians. Products developed from Tikun Olam’s proprietary strains, including its world-renowned Avidekel™ high-CBD strain, will be available in vape oils, tinctures and topical...

Read More